(+)-Talarozole
Product Specifications
UNSPSC Description
(+)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1.
Target Antigen
Autophagy; RAR/RXR
Type
Reference compound
Related Pathways
Autophagy;Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/__addition__-Talarozole.html
Solubility
DMSO : ≥ 72 mg/mL
Smiles
CCC(CC)C(C1=CC=C(NC2=NC3=CC=CC=C3S2)C=C1)N4N=CN=C4.[(+)].[Rotation]
Molecular Weight
377.51
References & Citations
[1]Marc Gaston Venet, et al. N-[4-(heteroarylmethyl)phenyl]-heteroarylamines. WO 1997049704 A1.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-14802C/plus-Talarozole-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-14802C/plus-Talarozole-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
201410-66-4
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Ignicoccus hospitalis Glutamate--tRNA ligase (gltX), partial
